ZURA

insider transactions

Zura Bio Ltd — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Net shares · 365d

-5.6K

0 buy · 5.6K sell

Net value · 365d

-$49.5K

$0 in · $49.5K out

Sentiment · 365d

Net selling

0% buying · 100% selling

Open-market trades · 365d

0 buy · 5.6K sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
Apr 1, 26

Gary Whale

Chief Technology Officer

$0

263.0K sh

Own New
Grant·A
Apr 1, 26

Kiran Nistala

Officer

$0

340.9K sh

Own New
Grant·A
Apr 1, 26

Sandeep Chidambar Kulkarni KEY

Chief Executive Officer

$0

894.0K sh

Own New
Grant·A
Apr 1, 26

Eric J Hyllengren KEY

Chief Financial Officer

$0

340.9K sh

Own New
Grant·A
Apr 1, 26

Kim Davis

Chief Legal Officer

$0

425.7K sh

Own New
Sell·S
Feb 25, 26

Mark Eisner

EVP and Chief Medical Officer · 10b5-1

$18.5K

1.9K sh · $9.82

Own -1%
Sell·S
Feb 24, 26

Mark Eisner

EVP and Chief Medical Officer · 10b5-1

$15.4K

1.6K sh · $9.53

Own -1%
Sell·S
Feb 23, 26

Mark Eisner

EVP and Chief Medical Officer · 10b5-1

$15.6K

2.1K sh · $7.45

Own -1%
Grant·A
Feb 22, 26

Mark Eisner

EVP and Chief Medical Officer · 10b5-1

$0

110.0K sh

Own New
Grant·A
Feb 22, 26

Mark Eisner

EVP and Chief Medical Officer · 10b5-1

$0

55.0K sh

Own +53%
Grant·A
Feb 21, 26

Ajay Nirula

Director

$0

37.8K sh

Own New
Grant·A
Feb 21, 26

Mark Eisner

Director

$0

37.8K sh

Own New
Grant·A
Jan 23, 26

Parvinder Thiara

Director

$0

38.8K sh

Own New
Grant·A
Jan 21, 26

Sandeep Chidambar Kulkarni KEY

Chief Executive Officer

$0

2.9M sh

Own New

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Apr 1, 2026	Gary Whale	Chief Technology Officer	Grant A	263.0K	New	—	$0
Apr 1, 2026	Kiran Nistala	Officer	Grant A	340.9K	New	—	$0
Apr 1, 2026	Sandeep Chidambar Kulkarni KEY	Chief Executive Officer	Grant A	894.0K	New	—	$0
Apr 1, 2026	Eric J Hyllengren KEY	Chief Financial Officer	Grant A	340.9K	New	—	$0
Apr 1, 2026	Kim Davis	Chief Legal Officer	Grant A	425.7K	New	—	$0
Feb 25, 2026	Mark Eisner 10b5-1	EVP and Chief Medical Officer	Sell S	1.9K	-1%	$9.82	$18.5K
Feb 24, 2026	Mark Eisner 10b5-1	EVP and Chief Medical Officer	Sell S	1.6K	-1%	$9.53	$15.4K
Feb 23, 2026	Mark Eisner 10b5-1	EVP and Chief Medical Officer	Sell S	2.1K	-1%	$7.45	$15.6K
Feb 22, 2026	Mark Eisner 10b5-1	EVP and Chief Medical Officer	Grant A	110.0K	New	—	$0
Feb 22, 2026	Mark Eisner 10b5-1	EVP and Chief Medical Officer	Grant A	55.0K	+53%	—	$0
Feb 21, 2026	Ajay Nirula	Director	Grant A	37.8K	New	—	$0
Feb 21, 2026	Mark Eisner	Director	Grant A	37.8K	New	—	$0
Jan 23, 2026	Parvinder Thiara	Director	Grant A	38.8K	New	—	$0
Jan 21, 2026	Sandeep Chidambar Kulkarni KEY	Chief Executive Officer	Grant A	2.9M	New	—	$0

About ZURA insider trading

This page tracks insider transactions for Zura Bio Ltd (ZURA) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.